Related Experiment Videos
Use of depo-provera in teens
Abstract:
Currently, depot-medroxyprogesterone acetate is the only contraceptive injection available in the United States. Its use was approved by the U.S. Food and Drug Administration in October 1992. This article describes the mechanisms of action, advantages, disadvantages, and contraindications of this very effective contraceptive agent. In addition, the initial workup, the treatment, and the follow-up of the teen receiving depot-medroxyprogesterone acetate are presented.
Keywords:
AdolescentsAdolescents, FemaleAge FactorsAmericasContraceptionContraceptive Agents, Female--beneficial effectsContraceptive Agents, Female--contraindicationsContraceptive Agents, Female--side effectsContraceptive Agents, Progestin--beneficial effectsContraceptive Agents, Progestin--contraindicationsContraceptive Agents, Progestin--side effectsContraceptive Agents--beneficial effectsContraceptive Agents--contraindicationsContraceptive Agents--side effectsContraceptive EffectivenessContraceptive Mode Of ActionDemographic FactorsDepo-provera--beneficial effectsDepo-provera--contraindicationsDepo-provera--side effectsDeveloped CountriesFamily PlanningLiterature ReviewMedroxyprogesterone Acetate--beneficial effectsMedroxyprogesterone Acetate--contraindicationsMedroxyprogesterone Acetate--side effectsNorth AmericaNorthern AmericaPopulationPopulation CharacteristicsUnited StatesYouth